These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 11003613)
1. Loss of nuclear p53 protein in preneoplastic rat hepatocytes is accompanied by Mdm2 and Bcl-2 overexpression and by defective response to DNA damage in vivo. Van Gijssel HE; Ohlson LC; Torndal UB; Mulder GJ; Eriksson LC; Porsch-Hällström I; Meerman JH Hepatology; 2000 Oct; 32(4 Pt 1):701-10. PubMed ID: 11003613 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas. Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P Anticancer Res; 1998; 18(2A):1167-73. PubMed ID: 9615783 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas. Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P Anticancer Res; 1998; 18(3A):1689-95. PubMed ID: 9673391 [TBL] [Abstract][Full Text] [Related]
5. Induction of preneoplastic rat liver lesions with an attenuated p53 response by low doses of diethylnitrosamine. Silins I; Stenius U; Högberg J Arch Toxicol; 2004 Sep; 78(9):540-8. PubMed ID: 15340777 [TBL] [Abstract][Full Text] [Related]
6. Characterizing the role of MDM2 in diethylnitrosamine induced acute liver damage and development of pre-neoplastic lesions. Finnberg N; Silins I; Stenius U; Högberg J Carcinogenesis; 2004 Jan; 25(1):113-22. PubMed ID: 14555611 [TBL] [Abstract][Full Text] [Related]
7. The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents. Gillet R; Grimber G; Bennoun M; Caron de Fromentel C; Briand P; Joulin V Oncogene; 2000 Jul; 19(31):3498-507. PubMed ID: 10918608 [TBL] [Abstract][Full Text] [Related]
8. Increased expression of cyclin G1 and p21WAF1/CIP1 in neurons following transient forebrain ischemia: comparison with early DNA damage. van Lookeren Campagne M; Gill R J Neurosci Res; 1998 Aug; 53(3):279-96. PubMed ID: 9698156 [TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage. Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077 [TBL] [Abstract][Full Text] [Related]
10. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue. Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P Anticancer Res; 1998; 18(4A):2403-8. PubMed ID: 9703886 [TBL] [Abstract][Full Text] [Related]
11. The in vivo apoptotic effect of interferon alfa-2b on rat preneoplastic liver involves Bax protein. de Luján Alvarez M; Cerliani JP; Monti J; Carnovale C; Ronco MT; Pisani G; Lugano MC; Carrillo MC Hepatology; 2002 Apr; 35(4):824-33. PubMed ID: 11915028 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders. Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372 [TBL] [Abstract][Full Text] [Related]
13. Lack of p53 protein expression in preneoplastic rat hepatocytes in vitro after exposure to N-acetoxy-acetylaminofluorene, X-rays or a proteasome inhibitor. van Gijssel HE; Stenius U; Mulder GJ; Meerman JH Eur J Cancer; 2000 Jan; 36(1):106-12. PubMed ID: 10741303 [TBL] [Abstract][Full Text] [Related]
14. p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1. Giannikaki E; Kouvidou C; Tzardi M; Stefanaki K; Koutsoubi K; Gregoriou M; Zois E; Kakolyris S; Mavroudi C; Delides G; Georgoulias V; Kanavaros P Anticancer Res; 1997; 17(3C):2123-7. PubMed ID: 9216675 [TBL] [Abstract][Full Text] [Related]
15. Heterozygous p53-deficient (+/-) mice develop fewer p53-negative preneoplastic focal liver lesions in response to treatment with diethylnitrosamine than do wild-type (+/+) mice. Finnberg N; Stenius U; Högberg J Cancer Lett; 2004 Apr; 207(2):149-55. PubMed ID: 15072823 [TBL] [Abstract][Full Text] [Related]
16. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma. Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040 [TBL] [Abstract][Full Text] [Related]
17. Early initiating and promoting effects in 2-AAF-induced rat liver carcinogenesis: an immunohistochemical study. Hadjiolov N; Bitsch A; Neumann HG Cancer Lett; 1995 Nov; 98(1):39-46. PubMed ID: 8529204 [TBL] [Abstract][Full Text] [Related]
18. Wild-type p53 expression in liver tissue and in enzyme-altered foci: an in vivo investigation on diethylnitrosamine-treated rats. Lennartsson P; Högberg J; Stenius U Carcinogenesis; 1998 Jul; 19(7):1231-7. PubMed ID: 9683182 [TBL] [Abstract][Full Text] [Related]
19. p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome. Pescarmona E; Pignoloni P; Puopolo M; Martelli M; Addesso M; Guglielmi C; Baroni CD J Pathol; 2001 Oct; 195(3):361-6. PubMed ID: 11673835 [TBL] [Abstract][Full Text] [Related]
20. The carcinogen 2-acetylaminofluorene inhibits activation and nuclear accumulation of cyclin-dependent kinase 2 in growth-induced rat liver. Lindeman B; Skarpen E; Oksvold MP; Huitfeldt HS Mol Carcinog; 2000 Mar; 27(3):190-9. PubMed ID: 10708481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]